This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Research » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Newborn Period Crucial Time Window to Prevent Later Diabetes

Posted: Sunday, November 06, 2011

A new approach to prevent type 2 diabetes may be on the horizon. The use of exendin-4 in newborns may prevent diabetes later in life.

Diabetes Drug Also Reduces Inflammation

Posted: Saturday, November 05, 2011

A GLP-1 drug prescribed to help patients with type 2 diabetes improve blood-sugar control also has a powerful anti-inflammatory effect, and the effect was observed within 2 hours following a single dose.

Pyridoxamine May Slow Early Diabetic Nephropathy

Posted: Saturday, November 05, 2011

Pyridoxamine (vitamin B6) is known to be an effective scavenger of reactive oxygen species and a potent inhibitor of advanced glycation end products. A new study demonstrated the benefits for patients with Type 2 diabetes.

Diabetes Medication Compliance a Major U.S. Issue

Posted: Sunday, October 23, 2011

We need to do a better job. Research by the New England Healthcare Institute shows that patients who don't take their medications as prescribed, cost the U.S. health care system an estimated $290 billion in avoidable medical spending each year.

FDA Approves Diabetes and Cholesterol-Lowering Drug Combo: Juvisync®

Posted: Sunday, October 09, 2011

Known as Juvisync (Merck), the new medication combines sitagliptin (Januvia, Merck), a dipeptidyl peptidase-4 (DPP-4) inhibitor used for glycemia control, with the cholesterol-lowering simvastatin.

New First in Class Glucagon Antagonists Show Promise for Diabetes

Posted: Sunday, September 25, 2011

New data on two investigational glucagon receptor antagonists suggest that this novel class of drugs has potential to be an effective treatment for type 2 diabetes.

Intensified Treatment with Basal Insulin Improves Control and Weight Loss

Posted: Saturday, September 24, 2011

Adding insulin detemir to a treatment regimen of metformin and liraglutide improved glycemic control and led to sustained weight loss for up to 52 weeks in patients with type 2 diabetes.

EASD: Outpatient Test Discriminates MODY from Type 1 Diabetes

Posted: Saturday, September 24, 2011

A measure of the postprandial ratio of urinary C-peptide to creatinine (UCPCR) can distinguish maturity-onset diabetes of the young (MODY) from type 1 diabetes mellitus, allowing some children who would otherwise be treated with insulin to receive oral antidiabetic agents alone.

EASD: Twice-Daily Aspirin Betters Platelet Inhibition for People with Diabetes

Posted: Monday, September 19, 2011

Twice-daily aspirin administration, but not a once-daily doubling of the dose, appears to provide good inhibition of platelet cyclooxygenase (COX)-1 in diabetic patients who have rapid recovery of COX-1 activity, and might enhance cardiovascular protection.

EASD: First Injection-free Once-A-Year GLP-1

Posted: Sunday, September 18, 2011

ITCA 650, injection-free continuous delivery of GLP-1 therapy, demonstrated significant and sustained reductions in HbA1c and body weight over 48 weeks of treatment with a marked reduction in the GI AEs typically associated with this class.